Jane Buchan - 14 Jul 2022 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Jane Buchan
Issuer symbol
IMMX
Transactions as of
14 Jul 2022
Net transactions value
$0
Form type
4
Filing time
18 Jul 2022, 06:05:47 UTC
Previous filing
28 Jun 2022
Next filing
29 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Options Award $0 +16,000 +53% $0.000000 46,000 14 Jul 2022 Common Stock 16,000 $2.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest monthly over 12 months from date of grant.